These findings are consistent with animal studies which suggest that, unlike in subjects with invasive breast cancer (in whom high levels of uPA are associated with a poor prognosis [24]), in high risk women the upregulation of uPA (in association with downregulation of PAI-1 and PGE2) may have a breast cancer chemopreventive effect. The gene discussed is SERPINE1; the disease is breast carcinoma.